MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,155K
EPS
-$0.02
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Selling, general and administrative
2,991
3,903
4,421*
1,933
Research and development
2,938
2,034
1,603*
597
Change in fair value of contingent consideration
-10
-4
-3,467*
-37
Total operating costs and expenses
5,919
5,933
2,556
2,493
Loss from operations
-5,919
-5,933
-2,556*
-2,493
Change in fair value of convertible notes
-213
-8,727
-17,314*
-1,877
Change in fair value of warrants
-4,941
-4,656
-19,552*
236
Loss on issuance of warrants
-
-
-18,911*
-
Loss on extinguishment of debt
-
-76
-
-
Loss on derivative liability
-
1,743
3,272*
-
Other income, net
36
30
50*
68
Total other (loss) income, net
4,764
-5,860
-19,895*
-2,045
(loss) income before taxes
-1,155
-11,793
-22,452
-4,538
Net (loss) income
-1,155
-11,793
-22,452
-4,538
Basic EPS
-0.02
-0.29
-3.19
-0.39
Diluted EPS
-0.02
-0.29
-3.19
-0.39
Basic Average Shares
50,530,946
40,614,087
7,039,006
11,634,946
Diluted Average Shares
50,530,946
40,614,087
7,039,006
11,634,946
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss) income
-$1,155K
(82.61%↑ Y/Y)
Change in fair value of
warrants
-$4,941K
(-1011.62%↓ Y/Y)
Other income, net
$36K
(-60.87%↓ Y/Y)
(loss) income before
taxes
-$1,155K
(82.61%↑ Y/Y)
Total other (loss)
income, net
$4,764K
(306.77%↑ Y/Y)
Change in fair value of
convertible notes
-$213K
(88.51%↑ Y/Y)
Loss from operations
-$5,919K
(-36.45%↓ Y/Y)
Total operating costs
and expenses
$5,919K
(36.45%↑ Y/Y)
Change in fair value of
contingent consideration
-$10K
(-162.50%↓ Y/Y)
Selling, general and
administrative
$2,991K
(-8.20%↓ Y/Y)
Research and development
$2,938K
(176.13%↑ Y/Y)
Buy us a coffee
AEON Biopharma, Inc. (AEON)
AEON Biopharma, Inc. (AEON)